Development and preclinical validation of a cysteine knottin peptide targeting integrin αvβ6 for near-infrared fluorescent-guided surgery in pancreatic cancer

WS Tummers, RH Kimura, L Abou-Elkacem… - Clinical Cancer …, 2018 - AACR
Purpose: Intraoperative near-infrared fluorescence (NIRF) imaging could help stratification
for the proper primary treatment for patients with pancreatic ductal adenocarcinoma (PDAC) …
被引用次数：53 相关文章

Development and Preclinical Validation of a Cysteine Knottin Peptide Targeting Integrin αvβ6 for Near-infrared Fluorescent-guided Surgery in Pancreatic Cancer.

WS Tummers, RH Kimura, L Abou-Elkacem… - … Cancer Research: an …, 2018 - europepmc.org
Purpose: Intraoperative near-infrared fluorescence (NIRF) imaging could help stratification
for the proper primary treatment for patients with pancreatic ductal adenocarcinoma (PDAC) …

Development and preclinical validation of a cysteine knottin peptide targeting integrin avb6 for near-infrared fluorescent-guided surgery in pancreatic cancer

WS Tummers, RH Kimura… - Clinical …, 2018 - researchinformation.amsterdamumc …
Purpose: Intraoperative near-infrared fluorescence (NIRF) imaging could help stratification
for the proper primary treatment for patients with pancreatic ductal adenocarcinoma (PDAC) …

[引用][C] Development and Preclinical Validation of a Cysteine Knottin Peptide Targeting Integrin alpha v beta 6 for Near-infrared Fluorescent-guided Surgery in …

WS Tummers, RH Kimura… - Clinical …, 2018 - scholarlypublications …
Development and Preclinical Validation of a Cysteine Knottin Peptide Targeting Integrin alpha
v beta 6 for Near-infrared Fluorescent-guided Surgery in Pancreatic Cancer | Scholarly …

Development and Preclinical Validation of a Cysteine Knottin Peptide Targeting Integrin αvβ6 for Near-infrared Fluorescent-guided Surgery in Pancreatic Cancer

WS Tummers, RH Kimura… - … : an official journal …, 2018 - pubmed.ncbi.nlm.nih.gov
Purpose: Intraoperative near-infrared fluorescence (NIRF) imaging could help stratification
for the proper primary treatment for patients with pancreatic ductal adenocarcinoma (PDAC) …